GlassScriptPhysician profile
Christopher T Perry
NPI 1366973752
$25,787.27
in general payments reported to CMS, 2019-2025
25 companies · $2,098 in 2025
The $2,098 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,280 · 2022: $849 · 2023: $17K · 2024: $2,410 · 2025: $2,098.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $14K · Travel and Lodging: $4,735 · Food and Beverage: $3,046 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $13,876.44 |
| Travel and Lodging | $4,734.56 |
| Food and Beverage | $3,046.12 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,112.73 | 2021-2024 | Micra |
| Abbott Laboratories | $7,204.87 | 2021-2023 | Ensite Precision |
| Biotronik INC. | $3,581.65 | 2021-2023 | |
| Boston Scientific Corporation | $2,638.47 | 2022-2025 | General - Vascular Access, Watchman Access System |
| Edwards Lifesciences Corporation | $2,150.25 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Stryker Corporation | $389.67 | 2025 | Flowtriever, Clottriever Bold Catheter |
| Abiomed | $329.79 | 2021-2024 | Impella |
| Amgen INC. | $321.06 | 2022-2023 | Repatha |
| Inari Medical, INC. | $274.36 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Angiodynamics, INC. | $191.55 | 2022-2025 | Alphavac |
| Terumo Medical Corporation | $97.95 | 2023 | Heartrail, Tr Band, Angio-Seal |
| Novo Nordisk INC | $71.49 | 2025 | Wegovy |
| E.R. Squibb & Sons, L.L.C. | $62.02 | 2024-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $59.69 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $50.54 | 2025 | Farxiga, Wainua |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $39.33 | 2025 | Verquvo, Capvaxive |
| Bayer Healthcare Pharmaceuticals INC. | $34.24 | 2024 | |
| Philips North America LLC | $29.02 | 2025 | Extended Holter |
| Bridgebio Pharma, INC. | $28.98 | 2025 | Attruby |
| Alnylam Pharmaceuticals INC. | $24.33 | 2025 | Onpattro |
| Verona Pharma, INC. | $21.39 | 2025 | Ohtuvayre |
| Kiniksa Pharmaceuticals International, Plc | $19.70 | 2024 | Arcalyst |
| Janssen Pharmaceuticals, INC | $19.18 | 2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.07 | 2025 | Lifevest |
| Penumbra, INC. | $15.94 | 2025 | Indigo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.